4.7 Article

Decoding empagliflozin's molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

Deepak L. Bhatt et al.

Summary: In patients with diabetes and recent worsening heart failure, treatment with sotagliflozin significantly reduced the total number of deaths from cardiovascular causes and hospitalizations and urgent visits for heart failure compared to placebo, regardless of the timing of administration.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cell Biology

HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction

Markus Wallner et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Medicine, General & Internal

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

Deep learning for cardiovascular medicine: a practical primer

Chayakrit Krittanawong et al.

EUROPEAN HEART JOURNAL (2019)

Review Biochemistry & Molecular Biology

Inflammatory and Molecular Pathways in Heart FailureIschemia, HFpEF and Transthyretin Cardiac Amyloidosis

Diana Michels da Silva et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Multidisciplinary Sciences

Nitrosative stress drives heart failure with preserved ejection fraction

Gabriele G. Schiattarella et al.

NATURE (2019)

Article Medicine, General & Internal

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

J. J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

S. D. Solomon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Biochemistry & Molecular Biology

ArrayExpress update - from bulk to single-cell expression data

Awais Athar et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Cardiac & Cardiovascular Systems

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes

Oriol Iborra-Egea et al.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)

Article Biochemistry & Molecular Biology

DrugBank 5.0: a major update to the DrugBank database for 2018

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Cardiac & Cardiovascular Systems

Do the SGLT-2 Inhibitors Offer More than Hypoglycemic Activity?

Eduardo Flores et al.

CARDIOVASCULAR DRUGS AND THERAPY (2018)

Review Endocrinology & Metabolism

SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review

Subodh Verma et al.

DIABETOLOGIA (2018)

Article Cell Biology

Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism

Mark Y. Jeong et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Multidisciplinary Sciences

Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence

David Romeo-Guitart et al.

SCIENTIFIC REPORTS (2018)

Review Cardiac & Cardiovascular Systems

Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes

Thomas A. Zelniker et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Role of Myocardial Collagen in Severe Aortic Stenosis With Preserved Ejection Fraction and Symptoms of Heart Failure

Kattalin Echegaray et al.

REVISTA ESPANOLA DE CARDIOLOGIA (2017)

Article Cardiac & Cardiovascular Systems

Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations

Julio A. Chirinos

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2017)

Article Cell Biology

Integrin Beta 3 Regulates Cellular Senescence by Activating the TGF-β Pathway

Valentina Rapisarda et al.

CELL REPORTS (2017)

Article Mathematical & Computational Biology

Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach

Oriol Iborra-Egea et al.

NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2017)

Article Cell Biology

Defining the Na+/H+ exchanger NHE1 interactome in triple-negative breast cancer cells

Schammim Ray Amith et al.

CELLULAR SIGNALLING (2017)

Article Biochemistry & Molecular Biology

STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data

Damian Szklarczyk et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Medicine, General & Internal

Spironolactone for Heart Failure with Preserved Ejection Fraction

Bertram Pitt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Physiology

Heart failure with preserved ejection fraction

James D. Gladden et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)

Article Multidisciplinary Sciences

Akt2 Regulates Metastatic Potential in Neuroblastoma

Jingbo Qiao et al.

PLOS ONE (2013)

Review Physiology

Mitochondrial NHE1: a newly identified target to prevent heart disease

Bernardo V. Alvarez et al.

FRONTIERS IN PHYSIOLOGY (2013)

Article Cardiac & Cardiovascular Systems

ERM proteins mediate the effects of Na+/H+ exchanger (NHE1) activation in cardiac myocytes

Amaria Darmellah et al.

CARDIOVASCULAR RESEARCH (2009)

Article Medicine, Research & Experimental

Activation of the Calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium

H. Diedrichs et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2007)

Article Physiology

NFAT regulates calcium-sensing receptor-mediated TNF production

HI Abdullah et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)

Article Biochemistry & Molecular Biology

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

R Edgar et al.

NUCLEIC ACIDS RESEARCH (2002)

Article Biochemistry & Molecular Biology

Calcineurin homologous protein as an essential cofactor for Na+/H+ exchangers

TX Pang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)